Non-Interventional Study: As provided in real world practice
Study summary
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
Eligibility
Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
1. Patient enrolled in IBD registry from 2009
2. \>18 years at time of diagnosis.
3. Diagnosis of Ulcerative Colitis.
4. Patient data entered during the study period.
5. Minimum duration of data post UC diagnosis (Cohort A: 6 months, Cohort B-D 6 months)
Primary outcome measure(s)
Proportion of patients that achieve early control of inflammation on conventional therapeutics within 6-24 months of UC diagnosis. — 6-24 months from UC diagnosis. Proportion of patients that achieve early control of inflammation on conventional therapeutics within 6-24 months of UC diagnosis in the Lothian inflammatory bowel disease registry (LIBDR).
Difference in proportion of patients with inadequate control of inflammation (defined as two or more episodes of raised CRP or faecal calprotectin) treated with conventional therapeutics versus treatment escalation 24 months post UC diagnosis. — 24 months Explore the differences in long term outcomes for patients with uncontrolled inflammation, treated with prolonged conventional therapeutics versus treatment escalation up to 24 months for patients with inadequate control of inflammation in the Lothian inflammatory bowel disease registry (LIBDR).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.